New Clinical Trial Applications
Please note that for all new Clinical Trial Applications received after the 7th of June 2021, there may be a delay in processing times of the application (over 60 days). This is due to low staffing levels during the month of July.

Substantial Amendment Applications
Please note that the principle of silent approval Substantial Amendment applications still applies. This means that the sponsor may implement the changes if the Regional Ethics Committee has approved the substantial amendment, and NoMA does not oppose the amendment within 35 days of receiving a valid application (in accordance with the Norwegian Regulation for Clinical Trials of 30-10-2009, § 5-1).

Applications for COVID-19 studies
We kindly request that you contact NoMA prior to any submissions for applications relating to COVID-19 studies so that we may prioritise the processing of these. Please send an email to and ensure that COVID-19 is included in the title of the email. 

​Fant du det du lette etter?